机构：[1]First Affiliated Hospital of Soochow University, Department of Cardiology, Suzhou City, Jiangsu Province, P.R. China[2]First Affiliated Hospital of Xi’an Jiaotong University, Department of Cardiology, Xi’an, Shaanxi, P.R. China[3]Beijing Anzhen Hospital, Capital Medical University, Beijing, PR China首都医科大学附属安贞医院[4]Doctor Evidence, Santa Monica, USA[5]Sanofi, General Medicine and Emerging Markets, Singapore
第一作者机构：[1]First Affiliated Hospital of Soochow University, Department of Cardiology, Suzhou City, Jiangsu Province, P.R. China
推荐引用方式(GB/T 7714)：
Zhou Yafeng,Guo Ning,Liu Wei,et al.Comparison of Dual Antiplatelet Therapy with Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome at High Risk of Bleeding[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2018,72(16):C110-C111.doi:10.1016/j.jacc.2018.08.545.
APA：
Zhou, Yafeng,Guo, Ning,Liu, Wei,Paek, Dara,Sayre, Toby&Girotra, Shalini.(2018).Comparison of Dual Antiplatelet Therapy with Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome at High Risk of Bleeding.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,72,(16)
MLA：
Zhou, Yafeng,et al."Comparison of Dual Antiplatelet Therapy with Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome at High Risk of Bleeding".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 72..16(2018):C110-C111
医学